NCT01293487 - Safety And Tolerability Study Of RN564 In Women With Osteopenia And Healthy Men. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 1, 2011

Primary Completion Date

May 24, 2012

Study Completion Date

May 24, 2012

Conditions

OsteopeniaOsteoporosisBone Disease

Interventions

BIOLOGICAL

RN564

Intravenous, single dose with experimental dose

Trial Locations (8)

SeaView Research, Inc., Miami

Ambulatory Diagnostic Center, Coral Gables

Gable Diagnostics, Coral Gables

Gables Diagnostics, Coral Gables

SeaView Research, Inc., Miami

Miami Research Associates, Miami

MRA Clinical Research, South Miami

Vince and Associates Clinical Research, Overland Park